In 2010, the global drug market for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.
Learn about the market for small–molecules and biologic therapies for diseases caused by disorders of the immune system. Get information on of various technology types used to contain undesirable immune responses and drugs in each category, key challenges, players in the market along with company profiles and patent analysis…
Use this report to:
- Understand how the most prevalent technologies in the immune system disorders therapeutic market have changed over the past decade with the advent of biologics and drugs with novel methods of delivery
- Identify the various regulatory and market trends that will impact major immune disease segments during the forecast period and how they will influence your future business strategies
- Examine the current market for the treatment of immune disease and develop effective marketing strategies based on the projected effects of new technologies upon this market
- Maintain a competitive standing with an in–depth analysis of leading companies and their successful strategies.
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.
GLOBAL MARKET FOR DRUGS TO TREAT IMMUNE DISEASES, 2009-2015
Source: BCC Research